Newark, New Castle, USA, April 18, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Growth Plus Reports, the global Femoral Nail System Market is expected to register a revenue CAGR of 5.8%.

DePuy Synthes’ Femoral Recon Nail System to treat femoral shaft fractures was launched in the U.S., pharmabiz.com reports. DePuy Synthes is part of the Johnson & Johnson Medical Devices Companies.

CORK, Ireland, Sept. 26, 2018 /PRNewswire/ -- OrthoXel™ is a specialist orthopaedic trauma company, using innovative engineering design to evolve ...

OrthoXel announced FDA 510(k) clearance of its Apex Femoral Nailing System. According to a company press release, the system provides multiple-trajectory locking options, including OrthoXel ...

CORK, Ireland, Nov. 20, 2018 /PRNewswire/ -- OrthoXel is a specialist orthopaedic trauma company, using innovative engineering design to evolve tr ...

Reference to recent studies, such as the work by Daniel E. Gerow, DO, and colleagues, which summarized the compatibility of various TKA implants with retrograde femoral nail systems, is crucial in ...

RENO, Nev.--(BUSINESS WIRE)--The Orthopaedic Implant Company (OIC) announced the launch of its Antegrade/Retrograde Intramedullary Femur Nail (ARFN) System today.The OIC ARFN Nail System is ...

--OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, today announced completion of the 1,000 th surgery utilizing its Pediatric Nailing Platform ...

DePuy Synthes' Femoral Recon Nail System to treat femoral shaft fractures was launched in the U.S., pharmabiz.com reports. DePuy Synthes is part of the Johnson & Johnson Medical Devices Companies.

The OIC ARFN Nail System is designed to treat femoral midshaft and distal fractures, providing for both retrograde and antegrade approaches in one implant design. The nail is available in ...